Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

B Arun, EP Frenkel - Expert opinion on pharmacotherapy, 2001 - Taylor & Francis
Topoisomerase I (topo-I) inhibitors are a new class of anticancer agents with a mechanism
of action aimed at interrupting DNA replication in cancer cells, the result of which is cell …
被引用次数：51 相关文章

Topoisomerase I inhibition with topotecan: Pharmacologic and clinical issues

B Arun, EP Frenkel - Expert Opinion on …, 2001 - utsouthwestern.elsevierpure.com
Topoisomerase I (topo-I) inhibitors are a new class of anticancer agents with a mechanism
of action aimed at interrupting DNA replication in cancer cells, the result of which is cell …

Topoisomerase I inhibition with topotecan: Pharmacologic and clinical issues

B Arun, EP Frenkel - Expert opinion on …, 2001 - mdanderson.elsevierpure.com
Topoisomerase I (topo-I) inhibitors are a new class of anticancer agents with a mechanism
of action aimed at interrupting DNA replication in cancer cells, the result of which is cell …

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

B Arun, EP Frenkel - Expert opinion on pharmacotherapy, 2001 - pubmed.ncbi.nlm.nih.gov
Topoisomerase I (topo-I) inhibitors are a new class of anticancer agents with a mechanism
of action aimed at interrupting DNA replication in cancer cells, the result of which is cell …

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues.

B Arun, EP Frenkel - Expert Opinion on Pharmacotherapy, 2001 - europepmc.org
Topoisomerase I (topo-I) inhibitors are a new class of anticancer agents with a mechanism
of action aimed at interrupting DNA replication in cancer cells, the result of which is cell …